Related Experiment Video
Updated: Jun 4, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Artificial intelligence in community pharmacy practice: Pharmacists' perceptions, willingness to utilize, and
Ashenafi Kibret Sendekie1,2, Liknaw Workie Limenh3, Biruk Beletew Abate4,5
1Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Background:
Artificial intelligence (AI) has a significant potential to impact pharmacy practices worldwide. This study investigates pharmacists' perceptions of AI's role in pharmacy practices, their willingness to adopt it, and perceived barriers to its implementation at community pharmacies in Ethiopia.
Methods:
A cross-sectional study was conducted among community pharmacists in Ethiopia. Data were collected using a self-administered questionnaire. Independent samples t-test, one-way ANOVA, and post-hoc analyses were used to compare pharmacists' perception and willingness scores. A linear regression analysis examined the association of independent variables with pharmacists' perception of AI and willingness to utilize AI. A p-value <0.05 was considered statistically significant.
Results:
Of 241 pharmacists approached, 225 (93.3 %) completed the survey. Overall, about two-thirds (67.1 % and 66.2 %) of community pharmacists had a high level of perception and willingness to use AI applications in pharmacy, respectively. Pharmacists with bachelor's degrees and above (β = 2.76: 95 % CI: 0.09, 5.01 vs. β = 1.79: 95 % CI: 0.05, 4.21), those who utilized scientific drug information sources (β = 2.45, 95 %: 0.17, 4.45 vs. β = 1.76, 95 % CI: 0.91, 3.89), pharmacists who had a previous exposure of AI (β = 1.02, 95 %: 0.03, 3.24 vs. β =1.13, 95 % CI: 0.07, 2.93), and those who with higher perceived AI knowledge (β =1.09, 95 % CI: 0.02, 2.46 vs. β = 1.14, 95 %CI: 0.17, 3.11) had significantly higher perception of AI and willingness to utilize it, respectively compared to their counterparts. Lack of internet availability (89.3 %), lack of AI-related software/hardware (88.2 %), and limited training (80.9 %) were the most frequently reported barriers by pharmacists to AI adoption. Over 90 % of pharmacists agreed on the importance of internet availability (93.3 %), policies/frameworks (91.6 %), and research/learning from others (89.3 %) for successful AI integration.
Conclusion:
Despite positive perceptions and willingness from pharmacists, AI implementation in community pharmacies could be hindered by resource limitations, training gaps, skill constraints, and infrastructure issues. To facilitate adoption, enhancing knowledge and skills, and developing policies/frameworks are crucial.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Current Trends in Nursing II
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Biopharmaceutics and Pharmacokinetics: Overview
Methods of Documentation III: PIE
Analysis of Population Pharmacokinetic Data

